RVNC - Revance Therapeutics Inc. (RVNC) CEO Mark Foley on Q4 2021 Results - Earnings Call Transcript
Revance Therapeutics, Inc. (RVNC) Q4 2021 Earnings Conference Call February 28, 2022, 04:30 PM ET Company Participants Jessica Serra – Head, IR & and ESG Mark Foley - CEO Dustin Sjuts - President Toby Schilke - CFO Conference Call Participants Ken Cacciatore - Cowen and Company Alena Seamus Fernandez - Guggenheim David Amsellem - Piper Sandler Annabel Samimy - Stifel Balaji Prasad - Barclays Tim Lugo - William Blair Douglas Tsao - H.C. Wainwright Serge Belanger - Needham & Company Presentation Operator 0:04 Welcome to Revance Therapeutics Fourth Quarter and Full Year 2021 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, we will hold a Q&A session. [Operator Instructions]. To ensure that we have ample time to address everyone's questions during the Q&A session, we will ask for a limit of one question and one follow up
For further details see:
Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q4 2021 Results - Earnings Call Transcript